OTCMKTS:BINDQ

(BINDQ) (BINDQ) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
660,601 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About (BINDQ)

DNIB Unwind, Inc., formerly BIND Therapeutics, Inc. is a shell company. The Company was engaged in developing targeted therapeutics, primarily for the treatment of cancer. As of August 1, 2016, the Company sold all of its assets. The Company's subsidiaries include BIND (RUS) LLC and DNIB Subsidiary Corporation.

BINDQ Stock News Headlines

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.
DNIB Unwind Inc (BINDQ)
See More Headlines
Receive BINDQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (BINDQ) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:BINDQ
Previous Symbol
NASDAQ:BIND
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

This page (OTCMKTS:BINDQ) was last updated on 5/10/2024 by MarketBeat.com Staff

From Our Partners